Spectrum of PD-1 and PD-L1 inhibitor cutaneous adverse events in skin of color: a retrospective, single-institutional study in an urban community.

MLA

Ngo, Tracy, et al. “Spectrum of PD-1 and PD-L1 Inhibitor Cutaneous Adverse Events in Skin of Color: A Retrospective, Single-Institutional Study in an Urban Community.” Acta Oncologica, vol. 60, no. 4, Apr. 2021, pp. 559–63. EBSCOhost, https://doi.org/10.1080/0284186X.2021.1878387.

APA

Ngo, T., Hossain, C., Guzman, A. K., Halmos, B., Balagula, Y., & McLellan, B. (2021). Spectrum of PD-1 and PD-L1 inhibitor cutaneous adverse events in skin of color: a retrospective, single-institutional study in an urban community. Acta Oncologica, 60(4), 559–563. https://doi.org/10.1080/0284186X.2021.1878387

Chicago

Ngo, Tracy, Claudia Hossain, Anthony K. Guzman, Balazs Halmos, Yevgeniy Balagula, and Beth McLellan. 2021. “Spectrum of PD-1 and PD-L1 Inhibitor Cutaneous Adverse Events in Skin of Color: A Retrospective, Single-Institutional Study in an Urban Community.” Acta Oncologica 60 (4): 559–63. doi:10.1080/0284186X.2021.1878387.